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INTRODUCTION 
 
Sleep Disordered Breathing and Spinal Cord Injury 
Over the past 3 decades sleep disordered breathing (SDB) in the general 
population has been the subject of increasing study due to the disorder’s negative 
impact on health and well-being. SDB is associated with excessive daytime sleepiness, 
impaired cognition and increased morbidity and mortality due to effects on the 
cardiovascular system, which include: hypertension, coronary artery disease (CAD), 
pulmonary hypertension, heart failure, atrial fibrillation, deep vein thrombosis (DVT) and 
increased risk of stroke (Gopalakrishnan and Tak, 2001; Mohsen and Urbano, 2011; 
Chou et al., 2012; Johansson et al., 2012).  Sleep disordered breathing is a general 
term that encompasses obstructive sleep apnea (OSA), in which patients experience 
apneas and/or hypopneas as a result of closure or narrowing of the upper airway during 
sleep, and central sleep apnea (CSA), in which apneas and/or hypopneas results from 
insufficient descending central ventilatory drive. Patients can also experience a 
combination of both types of SDB (Gilmartin et al., 2005). The prevalence of sleep 
apnea syndrome in the general population is estimated to occur in approximately 2-4% 
of adults per the Wisconsin Sleep Cohort Study (Young et al., 2002; Sean et al., 2005). 
An increased incidence of SDB after spinal cord injury (SCI) has been described 
in the literature over the past decade along with reports of poor sleep quality, sleep 
fragmentation with frequent arousals and daytime hypersomnolence. However, the 
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specific features of SDB in this population are poorly described and the underlying 
mechanisms are not understood. The prevalence of SDB after SCI has been reported 
as being between 27-77% depending on the source and level of injury (Bonekat et al., 
1990; McEvoy et al., 1995; Klefbeck et al., 1998; Burns, 2000; Stockhammer et al., 
2002; Berlowitz et al., 2009; Biering-Sorensen et al., 2009; Tran et al., 2009; Sankari et 
al., 2014).  Factors that account for the disparity in reported prevalence of SDB after 
SCI include: 1) the wide differences in methodologies used to diagnose sleep apnea in 
this population, which range from hospital-based sleep lab polysomnography (PSG), 
questionnaires of sleep disturbances (Biering-Sorensen et al., 2000), portable home 
sleep testing (Leduc et al., 2000),  overnight pulse oximetry to measure nocturnal 
oxygen desaturation and retrospective chart reviews (Burns et al., 2001, Leduc et 
al.,2007) and 2) the varying criteria and methods used to classify SDB.  
Factors that have been positively correlated with OSA in chronic SCI are much 
the same as those in the general population (obesity, increased neck circumference, 
age, gender) (Short et al., 1992) with the addition of the time from injury being an 
important factor as well as injury level (Stockhammer et al., 2002). Correlation with the 
American Spinal Injury Association (ASIA) impairment scale, which describes the motor 
and sensory extent of an injury, has been mixed (Burns et al., 2001, 2005; 
Stockhammer et al., 2002). However, a longitudinal study of SDB within the first year 
from injury (2 days to 52 weeks) after cervical spinal cord injury (cSCI) in male patients 
found no correlation between standard predictors of OSA and it’s occurrence (Burlowitz 
et al., 2005) as has been described in chronic cSCI by other investigators (Short et al., 
1992). Medications used to control pain and spasticity resulting from injury have been 
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implicated as possible contributing factors to SDB as well (Biering-Sorensen et al., 
2000), although the results of studies exploring the use of baclofen, the most commonly 
prescribed antispasmotic after SCI, have been mixed (Short et al., 1992; McEvoy et 
al.,1995; Klefbeck et al., 1998; Burns et al., 2000; Bensmail et al., 2006).  
Prior to 2014,  the predominant type of SDB identified in SCI patients was OSA 
(Young et al., 1993; Leduc et al., 2007). However, Sankari and colleagues (2014a) 
performed in-lab polysomnography (PSG) on 26 chronic (>1 year) SCI subjects (15 
cervical, 11 high thoracic) using quantitative  measurement of flow and upper airway 
pressure. The prevalence of SDB (i.e. an apnea hypopnea index >5 events/hour) in 
cervical SCI subjects was 93% versus 55% in thoracic SCI subjects. A novel finding 
was that 60% of cervical and 27% of thoracic subjects had CSA and periodic breathing 
(PB) (Sankari et al., 2014). Figure 1 depicts a representative example of CSA and PB in 
a cervical SCI subject.  Primary CSA occurs in <1% of the general population and is 
typically found in special populations such as premature neonates, patients with systolic 
heart failure, those ascending to high altitudes, and opiate users (Javaheri and 
Dempsey, 2013; Panossian et al., 2009; White et al., 2005). The CSA and PB identified 
in SCI subjects by Sankari et al. (2014) could not be explained by heart failure or 
narcotic use.  
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Figure 1. Periodic Breathing in Spinal Cord Injury 
 
A representative polygraph of central sleep apnea and periodic breathing in a C5-7 
cervical SCI subject (male, age 37 years, body mass index 28.5 kg/m2) in Non-REM 
sleep. Repetitive episodes of hyperpnea and hypopnea/apnea are indicative of periodic 
breathing. Supraglottic airway pressure signal (PSG) indicates that respiratory effort 
was greater during hyperpneas, diminished during hypopneas and absent during apnea 
indicating central sleep apnea. PETCO2: end tidal CO2, Mask P: mask pressure.  
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Ventilation after Spinal Cord Injury 
Loss of motor drive to respiratory muscles after cervical and high thoracic SCI 
results in impairment of respiratory function related to the level and completeness of 
injury. Injuries below the level of C5, or incomplete injuries typically leave the diaphragm 
sufficiently innervated to maintain ventilatory homeostasis during wake without the need 
for mechanical ventilation, although some hypoventilation may occur during wake and 
more frequently during sleep when higher brain center input to brainstem respiratory 
control centers is withdrawn (Castriotta and Murthy, 2009). Expiratory muscles (internal 
intercostals, pectoralis major and abdominal muscles) have the greatest magnitude of 
impairment compared with diaphragm and inspiratory accessory muscles in lower 
cervical and high thoracic injuries although varying levels of weakness in diaphragm 
and inspiratory accessory muscles are often present to some degree in lower cervical 
injury (Terson de Paleville et al., 2010). The external intercostals (inspiratory muscles) 
are of particular importance during sleep when their contribution to VT is ~20% in 
healthy humans (Tabachnik et al., 1981). Therefore, loss of external intercostal drive 
may contribute to sleep related hypoventilation after SCI (see Figure 2).  
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Figure 2. The Muscles of Respiration 
The human primary and accessory muscles of respiration are depicted with their level of 
spinal/cranial innervation and phase of respiratory activity (adapted from Schilero et al., 
2009). 
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 Decreased total lung capacity (TLC), forced vital capacity (FVC), forced 
expiratory volume at 1 second (FEV1), peak expiratory flow (PEF), inspiratory capacity 
(IC) and expiratory reserve volume (ERV) are typically observed in patients with cSCI 
(Schilero et al., 2009). In the supine position, FVC and FEV1 are typically higher in SCI 
patients due to the effect of gravity on abdominal contents (pushing up on the 
diaphragm) resulting in a greater upward curve in the diaphragm resulting in greater 
diaphragmatic excursions during inspiration as a result of a more favorable position of 
the muscle fibers on the length-tension curve. However, residual volume (RV) is smaller 
in the supine position (Schilero et al., 2009) also due to elevation of the diaphragm as a 
result of gravity on the abdominal contents. Thus, sleeping in the supine position may 
be accompanied by a decreased work of breathing in cSCI, but a lower RV may have 
implications for gas exchange such as lower arterial oxygen saturation (SaO2) and 
increased arterial carbon dioxide (Schilero et al., 2009).  
Putative Mechanisms for Sleep Disordered Breathing in SCI 
Cervical SCI patients have many ventilatory features that may predispose them 
to SDB, including but not limited to: respiratory muscle weakness, the loss of chest wall 
afferent input to brainstem respiratory control centers, hypoventilation, abnormal O2 and 
CO2 sensing, positional differences in blood pressure and ventilation, sympathetic 
nervous system dysregulation and related cardiovascular dysfunction, poor sleep 
quality, sleep fragmentation and the use of medications for pain and spasticity that may 
influence respiration during sleep (Teasell et al., 2000; Burns et al., 2001; Biering-
Sorensen et al., 2009; Castriotta and Murthy, 2009; Wilson et al., 2010) .  
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Periodic Breathing 
Periodic breathing (PB) during sleep is a type of central sleep disordered 
breathing in which ventilation waxes and wanes in a cyclical manner with periods of 
hypopnea and/or apnea with an accompanying rise in end-tidal CO2 (PETCO2) resulting 
in a period of hyperpnea with resultant hypocapnia which then begins the cycle again. 
These oscillations in respiration are typically accompanied by periods of oxygen 
desaturation during hypopnea/apnea followed by re-saturation during hyperpnic periods, 
as well as periods of hyper- and hypocapnia (Eckert et al., 2007).  Periods of oxygen 
desaturation and re-saturation are associated with the production of reactive oxygen 
species and intracellular inflammatory cascades that are implicated in the morbidity and 
mortality associated with SDB (Gopalakrishnan and Tak, 2001; Mohsen and Urbano, 
2011; Chou et al., 2012; Johansson et al., 2012).   
Specific conditions are known to precipitate PB and it can be experimentally 
induced in the lab using hypoxic conditions. Animal models of PB have shown that the 
mechanism in neonates (i.e. the lamb) is heightened sensitivity to hypoxia, which 
destabilizes breathing and increases loop gain or the peripheral chemoreceptor 
controller loop (Wilkinson et al., 1997). This is also the case in humans during sleep at 
high altitudes (Nussbaumer-Ochsner et al., 2012). In the premature infant PB is 
exacerbated by hypoxemia and relieved by administration of O2, CO2, or drugs that 
stimulate respiration (Darnall, 2010). 
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Periodic breathing can be induced by hypoxia, hypoventilation or respiratory 
depressants and mitigated by respiratory stimulants (i.e. caffeine) and breathing 
supplemental O2 or CO2. However, CO2 administration as long-term treatment for CSDB 
in the home is difficult to control and requires tight servo-control with breath to breath 
feedback of PETCO2 (dynamic CO2 administration) (Badr et al., 1994; Solin and 
Naughton, 2000; Mebrate et al., 2009) and is currently not being used clinically.  In 
patients with a narrow CO2 reserve (the difference between eupneic PETCO2 and the 
apneic threshold, which is the amount PETCO2 must be reduced to induce a central 
apnea) as we have found to be the case in many of our SCI subjects (Sankari et al., 
2014b), small perturbations in respiration lead to oscillations in PCO2 that result in CO2 
levels dipping below the apneic threshold causing central apnea to occur (Yumino and 
Bradley, 2008).  
According to Dempsey and colleagues (2009), the central apnea that commonly 
follows hyperpnea during periodic breathing appears to depend critically on hypocapnea 
being sensed by the peripheral chemoreceptors. However, there is close 
interdependence between central and peripheral chemoreceptors and it is difficult to 
ascertain the contribution of peripheral vs. central chemosensing when looking at the 
control of ventilation in the intact, otherwise healthy human (Xie et al., 2009, St Croix et 
al., 1996).  
Periodic breathing also occurs in patients with severe diastolic heart failure (HF). In 
Cheyne-Stokes respiration (CSR), a form of periodic breathing found in HF in cycles 
(time from peak to peak of hyperpneas) last approximately 60 seconds. This is in 
contrast to CSR or PB that is idiopathic or a result of ascent to altitude in which cycles 
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are approximately 35 seconds in duration. The longer cycle duration in HF is likely due 
to prolonged circulation time in these individuals as a result of poor cardiac function (Sin 
and Man, 2003; Yumino and Bradley, 2008; Binggeli et al., 2010). Heart failure patients 
with CSR are typically hypocapnic during wake and sleep with PaCO2 levels close to 
their apneic threshold. Approaches to PB in the HF point to a number of factors that can 
perpetuate unstable breathing cycles and so investigating the underlying mechanism 
and treatments in HF patients may give us critical insight into the mechanisms that 
contribute to periodic breathing after high SCI injury. The following are taken from 
literature that has investigated PB in the HF population:  
 
1) Chronic hypocapnia: Patients with HF and CSR-CSA have low PaCO2 during 
wake and sleep. The chronic hyperventilation is thought to be from pulmonary 
vagal irritant stimulation resulting from pulmonary congestion. In healthy 
individuals at the onset of sleep the apneic threshold increases but in HF PaCO2 
does not, so the CO2 reserve is smaller than in individuals without HF. The CO2 
reserve is a more important factor in breathing instability than the actual baseline 
PCO2 (Yumino and Bradley, 2007).  
 
2) Increased central and peripheral chemoreceptor sensitivity as a result of 
repeated exposure to hypoxia. This results in ventilatory overshoot  in response 
to changes in ventilation during sleep (Javheri, 1999; Solin et al., 2000). 
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3) Spontaneous arousals during sleep cause stimulation of ventilation from higher 
brain inputs. The resulting hyperpnea lowers PaCO2, leading to central apnea or 
hypopnea that perpetuates the periodic breathing cycle (Naughton et al., 1993).  
 
4) Abnormalities in cerebrovascular reactivity to CO2 lead to lower brain PaCO2. 
Normal reflex changes in cerebrovascular blood flow in response to changing 
[H+] serve to counter-regulate ventilation to stabilize breathing in the face of 
perturbations in PaCO2. The response to a reduction in CO2 or increased H+ 
should be to vasoconstriction that results in shielding of central chemoreceptors 
from transient drops in PaCO2. This phenomenon is called dampening. If 
cerebrovascular reactivity is reduced, the central chemoreceptors sense small 
changes in PaCO2 and ventilatory overshoot may occur that perpetuates periodic 
breathing (Yumino and Bradley, 2008; Xie et al., 2009). 
 
 
5) Decreased FRC: a large FRC acts as an O2/CO2 reservoir that dampens 
oscillations in PaO2/PaCO2 during apneas and stabilizes breathing. A low FRC 
leads to ‘under-dampening’ (Staniforth et al., 1997). In this case, the peripheral 
chemoreceptors would be exposed to frequent oscillations in O2 and CO2, which 
may lead to increased chemoreceptor sensitivity. This is unlikely to be the case 
in SCI subjects who typically have a FRC within normal limits (Stepp et al., 
2008). 
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6) Upper airway instability: The upper airway may collapse during central apneas. If 
airway resistance increases as ventilation decreases during the hypopnea phase 
of CSR or PB, hypoventilation may occur. Conversely, if there is decreased 
airway resistance during the hyperpnea phase, overshoot or hyperventilation is 
more likely to occur. So, upper airway resistance plays a key role in determining 
ventilation, as is well known in OSA, but potentially in central sleep disordered 
breathing as well. In addition, upper airway collapse itself may lead to central 
apnea as a reflex reaction (Sullivan et al., 1978; Badr et al., 1995). Thus, if upper 
airway resistance is a main contributor to periodic breathing or central apnea, 
treatment with CPAP will stabilize the upper airway and stabilize breathing.  
 
 
7) Hypoxia: As previously mentioned, hypoxia is well known to induce CSR and PB 
at high altitudes by causing hyperventilation as one attempts to improve PaO2, 
thus lowering PCO2 below apneic threshold. This type of CSA can be abolished 
by administration of O2, which alleviates the hypoxia, or by CO2 administration 
that brings the PaCO2 well above the apneic threshold resulting in a greater CO2 
reserve.  A transient drop in PaO2 occurs after prolonged apneas or hypopneas 
that can contribute to the magnitude of ventilatory overshoot that follows the 
apnea/hypopnea. Therefore, even mild hypoxic episodes may perpetuate CSR-
CSA (Khoo et al., 1982; Yumino and Bradley, 2008).  
 
Peripheral Chemoreception 
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  The primary peripheral chemoreceptors critical to the control of ventilation in 
adult humans are the carotid body chemoreceptors. Located bilaterally at the bifurcation 
of the carotid arteries, the carotid body chemoreceptors function to respond within 
seconds to changes in PaO2, PaCO2 and [H+] to regulate respiration according to 
metabolic requirements (Forster et al., 1999). Tonic afferent activity of the carotid body 
is required to maintain adequate ventilation under a wide range of physiologic 
conditions including wakefulness, NREM sleep and exercise. The activity of the carotid 
body chemoreceptors plays a critical role in regulating ventilation during NREM sleep 
when inputs from higher brain centers are quiescent, as they are the “first responders” 
to correct abnormalities in PaO2, PaCO2 and [H+] on a breath-by-breath basis.  Acute 
denervation of the carotid bodies results in hypoventilation in awake mammals in 
experimental preparations and clinically in humans with carotid body pathology that 
requires their excision (Gautier and Bonora, 1979; Honda et al., 1979; Lowry et al., 
1999; Kumar and Prabhakar, 2012).  
Oxygen sensing glomus (type I) cells of the carotid body are extensively 
innervated by fibers of the carotid sinus nerve, a branch of the glossopharyngeal nerve 
(CN IX) whose cell bodies are located in the petrosal ganglia. The petrosal ganglia are 
located in the commissural or medial subnuclei of the nucleus tractus solitaries (NTS), 
which is a major integration center in the brainstem for regulation of cardiac, autonomic 
and respiratory output (Kumar and Prabhakar, 2012). The primary neurotransmitters 
released peripherally at the synapse between glomus cells and afferent carotid sinus 
nerve endings are thought to be acetylcholine and ATP, which are released when the 
glomus cell is depolarized in response to hypoxia and/or increased [H+] or PCO2 (Lahiri 
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and Forster, 2003). James and Nantwi (2006) demonstrated in a rat model of cervical 
SCI that in carotid body intact animals, administration of a peripherally acting adenosine 
A2 receptor agonist (CGS-21680) followed by administration of a centrally acting 
adenosine A1 receptor antagonist (DPCPX, previously shown to elicit recovery of 
phrenic nerve activity after C2 hemi-section), resulted in greater phrenic nerve recovery 
compared to the recovery initiated in response to the administration of DPCPX alone. 
However, in carotid body denervated animals the same recovery of phrenic nerve 
activity in the affected nerve was not elicited. Thus James and Nantwi (2006) proposed 
that carotid body adenosine A2 receptors are involved in the excitation of central 
respiratory centers and are critical in recovery of respiratory function after cervical SCI 
(James and Nantwi, 2006).  
After entering the brainstem with the glossopharyngeal nerve, central afferent 
axons of carotid sinus neurons first synapse on chemosensitive respiratory network 
neurons in the caudal nucleus of the NTS to modulate respiration (Teppema and 
Dahan, 2010). A second synaptic site is an area of the parafacial respiratory group 
(pFRG), the retrotrapzoid nucleus (RTN). The RTN, located on the ventral medullary 
surface, is a putative chemosensitive and integrating area containing glutamatergic 
interneurons expressing the transcription factor Phox2b, a marker of chemosensitive 
neurons critical in the control respiration, particularly during sleep (Guyenet, 2008; 
Forester and Smith, 2010). RTN neurons project to the ventral respiratory group (VRG), 
that act directly on phrenic neurons. Studies over the past decade indicate that the 
function of the carotid body peripheral chemoreceptors is to rapidly modulate the gain of 
central chemoreceptors, although historically there has been much debate over how the 
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peripheral and central chemoreceptors interact, whether their interactions are simply 
additive or hyper-additive (Clement et al., 1995; Forster et al., 2007; Nuding et al., 2009; 
Xie et al., 2009; Dempsey et al., 2012). 
Under conditions of chronic hypoxia (sustained hypoxia [SH]), which is 
experienced by non-natives residing at high altitudes, the carotid body undergoes 
acclimatization during which respiratory drive is increased to stimulate ventilation along 
with a concurrent increase in their sensitivity to O2 (increased peripheral chemoreceptor 
gain). Under this chronic condition carotid body will eventually become hypertrophied 
with increased vascularization and an increase in the number of glomus cells (Lahiri, 
2003). Under conditions  chronic intermittent hypoxia (CIH), as occurs with SDB, such 
anatomical changes do not take place, rather a reversible functional plasticity of the 
carotid bodies occurs, known as sensory long-term facilitation (LTF) (MacFarlane and 
Mitchell, 2003; Peng et al., 2003; Peng and Prabhakar, 2003).    
Augmented sensitivity of the carotid body to O2 and CO2 has been implicated as 
a mechanism by which breathing instability during sleep (CSA or PB) can be elicited 
and/or sustained (Dunai et. al., 1999; Dempsey, 2004; Eckert et al., 2007). Modeling 
studies of the respiratory control loop have identified peripheral chemoreflex responses 
as a key factor in PB (Khoo et al., 1982 and 1991). Individuals with high peripheral 
chemosensitivity will “over correct” for relatively small perturbations in CO2 or O2 with 
hyperpnea that results in CO2 falling very near or below the apneic threshold causing 
apnea/hypopnea, which continues the cycle. The strong relationship between PB and 
heightened peripheral chemosensitivity suggests a putative mechanism for SDB in SCI.  
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Conclusions 
In conclusion, it is clear that SDB poses a significant threat to vital organ systems that 
lead to increased morbidity and mortality in the general population. The observation that 
SDB is more prevalent after SCI compared to spinal cord intact populations makes the 
study of this disorder of critically important in this population.  The discovery of a high 
percentage of CSDB in high SCI in studies conducted thus far in our lab (approximately 
75% in cervical SCI subjects studied) suggests specific mechanisms to focus on, 
namely the role of sleep-onset hypoventilation and peripheral chemoreceptor sensitivity. 
Valuable information may be uncovered by targeting and exploring the specific features 
of chemoreception after high thoracic and cervical SCI that may lead to a greater 
understanding of the mechanisms involved in the development of SDB in this 
population. Understanding the key mechanisms will aid in the development of future 
therapeutic targets. In addition, involvement of hypoventilation in the development of 
SDB after SCI is a critical mechanism to explore as chronic sleep-related 
hypoventilation may underlie changes in chemoreflex sensitivity after SCI.  
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CHAPTER 1 
Sleep Onset Hypoventilation in Chronic Spinal Cord Injury 
Introduction 
 Patients with spinal cord injury suffer from poor nocturnal sleep, sleep 
fragmentation and high prevalence of SDB (Bonekat et al., 1990; Klefbeck et al., 1998; 
Burns et al., 2000; Berlowitz et al., 2005; Sankari et al., 2014a). However, the 
underlying mechanisms are not understood. What is clear, is that SDB in chronic SCI 
poses a significant quality of life issue for this population due to excessive daytime 
sleepiness, chronic fatigue and cognitive impairment (Ayas et al., 2014; Sankari et al., 
2014a; Vaessen et al., 2014), as well as increased risk of cardiovascular morbidity and 
mortality that accompanies under-diagnosed and untreated SDB (Caples et al., 2007; 
Marshall et al., 2014).   
The prevalence of SDB after SCI has been reported as being between 27-77% 
(Bonekat et al., 1990; McEvoy et al., 1995; Klefbeck et al., 1998; Burns et al., 2000; 
Stockhammer et al., 2002; Berlowitz et al., 2005; Biering-Sorenson et al., 2009; Tran et 
al., 2010; Sankari et al., 2014a and 2014b). In contrast, the prevalence of sleep apnea 
syndrome in the non-injured population, which is estimated to occur in approximately 2-
4% (depending upon age and gender) according to data from the Wisconsin Sleep 
Cohort Study (Peppard et al., 2013). Work from Sankari and colleagues (2014a) has 
revealed that three out of four chronic SCI patients have symptomatic SDB, with central 
SDB noted in cervical SCI and obstructive SDB in thoracic SCI (Sankari et al., 2014a 
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and 2014b). Furthermore, Sankari et al. (2014b) found that a narrowed CO2 reserve in 
patients with cervical SCI was associated with increased steady-state plant gain, which 
reflects the effectiveness of the respiratory system to eliminate CO2 for a given alveolar 
ventilation level. Accordingly, increased steady-state plant gain may promote the 
development of central apnea upon transition to non-REM sleep when breathing is 
mainly dependent on chemical stimuli. However, the etiology of increased plant gain 
and breathing instability during sleep in this SCI population, who may have normal gas 
exchange during wakefulness, versus able-bodied individuals is not known.  
Cervical and high thoracic SCI results in disruption of descending bulbospinal 
pathways to the muscles of respiration, such as the diaphragm (C3-C5), intercostals 
(T1-T11) and abdominals (T6-L3) (Zimmer et al., 2008; Schilero et al., 2009). Such 
disruption results in respiratory muscle weakness or paralysis depending upon level and 
completeness of injury.  Hypoventilation resulting from restrictive ventilatory mechanics, 
which worsens during sleep, has been proposed as a mechanism for the development 
of sleep disordered breathing in spinal cord injury (Castriotta and Murthy, 2009). 
I hypothesized that Individuals with SCI would develop a greater degree of sleep-
related hypoventilation compared to able-bodied controls. To this end, I measured 
ventilation and upper airway resistance during transitions from alpha (8-12 Hz, wake) to 
theta (4-7 Hz, stage N1 sleep). 
 
Materials and Methods 
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Subjects 
Protocols were approved by the Human Investigation Committee of the John D. 
Dingell Veterans Affairs Medical Center and Wayne State University (Detroit, MI) and 
written informed consent was obtained.  
We studied adults (≥18 years old) with chronic SCI and able-bodied participants 
if they met the inclusion and exclusion criteria. All subjects were instructed not to have 
alcohol, caffeine products or sedatives on the day of the study.  
Inclusion Criteria: Participants with chronic SCI (>6 months post-injury), spanning 
the spectrum from cervical (cSCI, C4-C7) to thoracic levels (tSCI, T1-T6) (complete and 
incomplete injuries). Able-bodied subjects (AB) were recruited with similar 
demographics to the SCI group for age, body mass index (BMI) and gender.  
Exclusion Criteria: Participants were excluded from the study for any of the 
following: (1) pregnant or lactating females; (2) currently ventilator dependent or with 
tracheostomy tube in place; (3) history of cardiac disease including heart failure, 
peripheral vascular disease, or stroke; (4) history of head trauma resulting in 
neurological symptoms or loss of consciousness; (5) advanced lung, liver, or chronic 
kidney disease; (6) extreme obesity, defined for this protocol as BMI >38 kg/m2; or (7) 
other illness that would interfere with completion of the study.  
The first visit to the lab consisted of documenting medical history, physical exam 
that included vital signs, maximal inspiratory and expiratory pressures (MIP and MEP) 
for SCI individuals, and spirometry to rule out pulmonary disease. The second visit 
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consisted of an overnight polysomnography (PSG). If the subject had a concern about 
sleep difficulties, Zolpidem was administered orally 30 minutes prior to beginning of 
recordings to minimize sleep difficulties.  Zolpidem dose was selected based on the 
subject’s age (≥60 years old: 5 mg, <60 years: 10 mg IR or 12.5 mg CR). The number of 
subjects requiring Zolpidem was similar in both groups (Table 1).  
Polysomnography (PSG) 
Subjects arrived at the lab between 8:00-9:00 pm to be instrumented and 
prepared for study. PSG was performed in the supine position using the Comet PSG 
System (AS40 Model) or the Heritage II PSG System (Grass Technologies, Warwick, 
RI). Measurements included electrocardiogram (ECG), electroencephalogram (EEG), 
electrooculograms (EOG) and chin electromyogram (EMG) using the International 10-
20 system of electrode placement (EEG: C3-A2 and C4-A2; EOG: O-A2). Subjects wore 
a nasal mask connected to a pneumotachometer (Hans Rudolph, Model 3700A, 
Shawnee, KS) that measured airflow. Tidal Volume (VT) was determined via integration 
of the pneumotachometer flow signal. End-tidal carbon dioxide (PETCO2) and end-tidal 
oxygen (PETO2) levels were measured with CO2 and O2 gas analyzers (Vacumed Model 
17515 and 17518 respectively, Ventura, CA). Supraglottic airway pressure was 
measured with a pressure tipped catheter (Millar Instruments, Houston, TX) placed 
through one nostril and extending down into the hypopharynx at least 2 cm caudal to 
the visible base of the tongue and superior to the epiglottis. Pulse oximetry was 
measured via ear probe (Biox 3740, Datex-Ohmeda Inc, Madison, WI). Subjects were 
recorded while breathing spontaneously on room air. Ventilation data from the 
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pneumotachometer, supraglottic catheter, pulse oximeter and gas analyzers were 
digitized and analyzed using a PowerLab Data Acquisition System (Model 16SP, 
ADInstruments Inc., Colorado Springs, CO).  
 
Data Analysis 
PSGs were scored using American Academy of Sleep Medicine (AASM) 2012 
recommended criteria (Berry et al., 2012). Supraglottic pressure and respiratory 
inductance plethesmography (RIP) bands (Respitrace, model 200, Nims inc., Miami 
Beach, FL) were used to differentiate between obstructive and central apneas. In order 
to analyze state-specific changes in ventilation, transitions between wake and sleep 
were identified first. Sleep stage scorers were blinded to ventilation. Blinding of 
ventilation signals was accomplished by covering the portion of the screen that 
contained ventilation signals. Two independent sleep scorers identified and verified 
agreement of wake to sleep transitions. Occipital EEG signals were used to determine 
the predominance of alpha (resting wakefulness with eyes closed, 8-12 Hz) vs. theta 
(stage N1 sleep, 4-7 Hz) waves without K complexes or sleep spindles. 
After identification of 3 separate alpha to theta transitions, ventilation data were 
obtained and analyzed from time-matched segments (Figure 3). In the case that 3 
transition segments could not be identified for the subject, two transitions were used. In 
the SCI group, we analyzed 47 transitions (137 and 134 breaths in alpha and theta 
respectively). In the AB group, we analyzed 40 transitions (112 and 108 breaths in 
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alpha and theta respectively). Ventilation data obtained consisted of breath-by-breath 
minute ventilation (VE), tidal volume (VT), respiratory frequency (ƒ), inspiratory time (Ti), 
expiratory time (Te), total cycle time (Ttot), oxygen saturation (SaO2), PETCO2 and 
PETO2. Inspiratory RUA was calculated at the linear portion of the pressure-flow 
relationship using the pressure-flow loops (supraglottic pressure and airflow).  
Alpha to theta transitions were only analyzed if there were at least two thirty-
second epochs of wake preceding the transition so that brief arousals from sleep with 
corresponding hyperpneas were not used. We did not analyze any transitions from theta 
to alpha (arousals from sleep). For each subject, all ventilatory parameters for alpha 
breaths were grouped and averaged as well as theta breaths. Comparisons were then 
made between groups and conditions (alpha vs. theta). 
To verify the accuracy of visual scoring of segments selected for analysis, we 
performed spectral analysis using Fast Fourier Transform (FFT) method (MATLAB, 
Math Works inc., Natick, MA) on EEG segments selected for alpha and theta analysis in 
4 subjects. We found > 90% agreement between visual scoring and spectral analysis 
and thus proceeded with visual classification (Trinder et al., 1992; Yang et al., 2012).  
In breaths where significant hypopnea or apnea occurred, PETCO2 signals were invalid 
in some breaths due to insufficient flow to capture end-tidal plateau. In such cases, the 
PETCO2 values were eliminated (not factored into average PETCO2 for that segment).  
Thus, only breaths with reliable signals were used for PETCO2 analysis, but the VE, VT 
and ƒ for hypopneas were valid and were used in analysis. When apnea occurred, the 
total time of the apnea was considered as part of the Te of the breath before apnea, 
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thus VE for that breath reflected the overall decrease in ventilation as a result of the 
apnea.  
Three secondary analyses were performed: 1) Sleep onset changes in ventilation were 
compared between cervical and thoracic SCI subjects to determine the effect on injury 
level on ventilation.  2) To determine the potential confounding effect of SDB on sleep 
onset ventilatory changes, we compared sleep onset changes in ventilation in 8 cervical 
SCI individuals and 8 able-bodied controls with SDB. 3) To determine the potential 
contribution of intercostal muscle atonia on sleep onset changes in ventilation, we 
analyzed the transition from non-REM to REM sleep in a subset of subjects in each of 
the following groups who had REM sleep: cervical SCI (n=3), thoracic SCI (n=2), and 
able-bodied subjects (n=3).  
 
Statistical Analysis 
Two-way repeated measures ANOVA (Sigma Plot 12.1) was performed to 
determine within group (e.g. alpha to theta changes in cSCI) and between group 
differences in ventilatory parameters and upper airway resistance between the two 
conditions: alpha and theta EEG frequencies. When appropriate, post-hoc pair-wise 
multiple comparisons were made using the Student-Newman-Keuls method. When data 
were not normally distributed, appropriate non-parametric analysis was employed. T-
tests were used to compare all demographic data between AB and SCI. All data are 
reported as mean ± SD and significance was set at p<0.05. 
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Results 
Sleep onset ventilatory changes  
We studied 18 subjects with SCI and 17 AB with similar demographics (Table 1). 
In figure 3 we show an illustration of tidal volume (VT) decrease during the transition 
from alpha to theta in a representative cSCI subject. The effect of wake to sleep 
transition on ventilation in a representative AB subject is shown in figure 4.  Group 
changes in VT and VE during sleep-onset transitions are detailed in figure 5 (panels A 
and B). Sleep onset was associated with significant decrease in VT and VE in the SCI 
but not the AB subjects. However, there was no significant change in RUA with sleep 
onset in either group (Figure 6). 
The effect of sleep onset on ventilatory parameters in SCI and AB groups is 
summarized in Table 2. Sleep onset in the SCI group was associated with decreased Ti 
while lengthening Te, reduced duty cycle (Ti/Ttot) and unchanged respiratory frequency 
and Ttot. In contrast, the AB group demonstrated increased respiratory frequency at 
sleep onset with no significant changes in Ti, Te, or Ttot.   
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Table 1. Subject Characteristics 
 SCI Able-Bodied p value 
N 18 17 NS 
Age (years) 42.4±17.1 42.9±13.9 NS 
BMI (kg/m2) 26.3±4.8 27.8±5.4 NS 
Gender (M/F) 11/7 8/9 NS 
NC (cm) 38.5±3.0 37.1±3.7 NS 
AHI (events/hr) 22.9±22.4 7.3±8.8 p<0.05 
AHI (>5 events/hr) 12 8 -- 
Zolpidem (Y/N) 9/9 8/7 NS 
Injury Level (cervical/thoracic) 10/8 -- -- 
MIP (% predicted) 87.2±29.4 -- -- 
MEP (% predicted) 42.3±15.8 -- -- 
FVC (% predicted) 71.5±17.0 86.5±26.5 NS 
FEV 1(% predicted) 76.4±16.7 87.6±18.4 NS 
FEV1/FVC 80.5±7.0 77.6±9.6 NS 
All data mean ± SD.  BMI: body mass index, NC: neck circumference, AHI: apnea 
hypopnea index, MIP: maximal inspiratory pressure, MEP: maximal expiratory pressure, 
FVC: forced vital capacity, FEV1: forced expiratory volume at 1 second, FEV1/FVC: the 
ratio of FEV1 to FVC, NS: not significant. 
 
  
26 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2. Effect of Sleep Onset on Respiratory Cycle Timing and Chemical 
Stimuli 
                SCI          Able-Bodied 
 Alpha Theta Alpha Theta 
Frequency 
(breaths/min) 
15.3±3.1 14.9±3.9 15.3±2.5 16.2±2.9ǂ 
Ti (sec) 1.8±0.4 1.7±0.3ǂ 1.8±0.3 1.7±0.4 
Te (sec) 2.4±0.7 3.0±1.6ǂ 2.3±0.5 2.2±0.5* 
Ti/Ttot 0.44±0.05 0.40±0.08ǂ 0.43±0.05 0.44±0.07 
SaO2 (%) 96.1±1.4 95.8±1.7 96.2±1.0 96.2±0.9 
PETCO2 
(mmHg) 
38.9±2.7 40.6±3.4ǂ 39.5±3.2 39.9±3.2 
PETO2 
(mmHg) 
94.1±7.1 91.2±8.3ǂ 99.4±5.4 98.9±6.1 
All data mean ± S.D. SCI n=18, AB n=17. * between-group (SCI vs. Able-
Bodied) difference p<0.05, ǂ within-group difference (alpha vs. theta) 
p<0.05. Ti: inspiratory time, Te: expiratory time, Ti/Ttot: ratio of ti to total 
cycle time. 
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Figure 3: Transition from Alpha to Theta in Cervical Spinal Cord Injury 
Panel A: A representative polygraph with EEG and EMG recordings in a 36 year old 
chronic cervical (C6, incomplete injury) SCI individual (male, BMI 28.2 kg/m2) during the 
transition from wake (alpha) to N1 sleep (theta). E: eye, M: mastoid ground, C: central, 
O: occipital. Panel B: A 30 seconds polygraph with ventilation recording, time matched 
to the EEG data in panel A. Note the reduction in flow and tidal volume with sleep-onset 
evident in panel B. VT: tidal volume; PSG: supraglottic pressure; PETCO2: end-tidal CO2; 
PETO2: end-tidal O2.  
  
28 
 
 
Figure 4: Transition from Alpha to Theta in an Able-Bodied Subject 
Panel A: A representative polygraph with EEG and EMG recordings in a 55 year old 
able-bodied subject (male, BMI 27 kg/m2) during the transition from wake (alpha) to N1 
sleep (theta). E: eye, M: mastoid ground, C: central, O: occipital. Panel B: A 30 second 
polygraph of ventilation, time matched to the EEG data in panel A. VT: tidal volume; 
PSG: supraglottic pressure; PETCO2: end-tidal CO2; PETO2: end-tidal O2.  
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Figure 5: Effect of Sleep Onset on Ventilation 
Panel A illustrates a greater decrease in tidal volume (VT) with sleep onset in SCI 
compared to able-bodied subjects. Panel B illustrates the greater decrease minute 
ventilation (VE) at sleep onset in SCI group compared with able-bodied group.  
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Figure 6: Effect of Sleep Onset on Upper Airway Resistance 
There was no significant change in upper airway resistance at sleep onset in SCI or 
able-bodied subjects. Between-group (SCI vs. Able-bodied) difference p = 0.624; within 
group (SCI-alpha vs. theta, Able-bodied-alpha vs. theta) difference p= 0.954. 
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Comparison of cervical vs. thoracic SCI: 
To determine if spinal injury level influenced sleep onset ventilation, we 
compared the ventilatory parameters detailed above between cSCI (n=10) and tSCI 
(n=8) subjects. Alpha to theta transitions were associated with significantly decreased 
VT in cSCI subjects (alpha: 576.0±256.3 mL, theta: 293.1±105.8 mL, p<0.05) but not in 
tSCI (alpha: 445.2±100.9 mL, theta: 364.6±90.7 mL, p=ns). Similarly, VE was 
significantly reduced in cSCI (alpha: 7.8±2.6 L, theta: 4.3±1.6 L, P<0.05) compared to 
tSCI (alpha: 6.9±1.5 L, theta: 5.6±1.4 L, p=0.08). Thus, injury level has a significant 
impact on sleep onset hypoventilation.  Further results of cSCI vs. tSCI analyses are 
detailed in Table 3.   
Effect of sleep disordered breathing on sleep onset hypoventilation in cervical SCI and 
able-bodied subjects  
To determine the potential contribution of SDB to sleep-onset hypoventilation in 
the cSCI group; we compared 8 cSCI individuals and 8 AB subjects with SDB as 
defined by an AHI ≥ 5 events/hour.  Sleep onset was associated with decreased VT and 
VE in participants with cSCI and SDB, but not in AB subjects with SDB (Table 4). 
Changes in other ventilatory parameters are detailed in Table 4. Thus, cSCI with SDB 
have a significantly greater reduction in ventilation with sleep onset compared to AB 
subjects with SDB.   
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Table 3. Cervical vs. Thoracic SCI: Sleep Onset Ventilation 
              cSCI    tSCI 
 Alpha Theta Alpha Theta 
Frequency 
(breaths/min) 
14.7±3.3 14.2±4.5 15.9±3.0 15.7±2.9 
Ti (sec) 1.9±0.4 1.7±0.4ǂ 1.7±0.3 1.6±0.3 
Te (sec) 2.5±0.7 3.51±2.0 2.3±0.7 2.4±0.6 
Ti/Ttot 0.44±0.04 0.38±0.09ǂ 0.43±0.06 0.42±0.06 
SaO2 (%) 95.8±1.3 95.1±1.6 96.6±1.4 96.7±1.4* 
PETCO2 
(mmHg) 
38.9±3.2 41.3±4.1ǂ 38.9±1.7 39.5±1.8 
PETO2 
(mmHg) 
94.3±4.8 90.6±6.8ǂ 93.8±10.1 92.0±10.6 
 
RUA 
(cmH2O/L/sec) 
3.61±1.7 3.5±1.9 3.5±1.4 3.6±1.7 
All data mean ± S.D.  cSCI: cervical SCI; tSCI: thoracic SCI. cSCI n=10, tSCI n=8. * 
between-group (cervical vs. thoracic) difference P˂0.05, ǂ within-group difference 
(alpha vs. theta)  P˂0.05.  Ti: inspiratory time, Te: expiratory time, Ti/Ttot: ratio of Ti to 
total cycle time, RUA: upper airway resistance. 
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Table 4. Cervical SCI vs. Able-Bodied Subjects: Effect of Sleep Disordered 
Breathing on Sleep Onset Ventilation  
 cSCI Able-Bodied 
 Alpha Theta Alpha Theta 
Frequency 
(breaths/min) 
 
14.4±3.5 13.9±5.1 15.7±2.3 17.3±3.2 
VE (L/min) 7.4±2.6 4.4±1.8ǂ 6.6±2.4 6.1±2.1 
VT (L) 
0.58±.26 0.30±0.12ǂ 0.43±0.18 0.37±0.16 
Ti (sec) 2.0±0.5 1.8±0.4ǂ 1.7±0.1 1.5±0.2 
Te (sec) 2.6±0.7 3.8±2.1ǂ 2.2±0.6 2.1±0.7* 
Ti/Ttot 0.44±0.04 0.37±0.09ǂ 0.43±0.06 0.44±0.07 
SaO2 (%) 95.8±1.4 95.1±1.8 96.0±1.3 96.1±1.1 
PETCO2 
(mmHg) 
39.3±3.1 41.6±3.4ǂ 39.6±2.6 39.8±2.2 
PETO2 
(mmHg) 
94.6±5.0 91.4±6.5ǂ 101.1±4.2 100.4±5.9* 
RUA 
(cmH2O/L/sec) 
3.4±1.3 3.2±1.7 4.3±2.9 4.8±5.2 
All data mean ± SD.  cSCI: cervical SCI;  cSCI n= 8, able-bodied (AB) n=8. * between-
group (cSCI vs. AB) difference p˂0.05, ǂ within-group difference (alpha vs. theta) 
p˂0.05.  VE: minute ventilation, VT: tidal volume, Ti: inspiratory time, Te: expiratory time, 
Ti/Ttot: ratio of Ti to total cycle time, RUA: upper airway resistance. 
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Comparison of ventilation with REM onset in cervical and thoracic SCI and able-bodied 
subjects 
To ascertain the relative contribution of the loss of intercostal muscle activity on sleep 
onset hypoventilation, we compared the ventilatory changes during non-REM to REM 
transitions. We reasoned that the magnitude of non-REM to REM ventilatory changes 
would be attenuated in individuals with cSCI because of the loss of intercostal muscle 
activity. There was a paucity of REM sleep in all subjects, owing to the high level of 
instrumentation in our protocols.  We identified non-REM to REM transitions in a sub-set 
of 3 cSCI individuals, 2 tSCI subjects and 3 AB subjects. A single transition from non-
REM to REM sleep was analyzed for each subject (3 transitions in cSCI and AB, 2 
transitions in tSCI group). The 10 non-REM breaths immediately prior to REM onset 
were analyzed for tidal volume in each group, as well as for the first 10 breaths of REM 
sleep. Any breaths associated with an arousal were not included in the analysis. The 
onset of REM was determined using the AASM 2007 guidelines (Iber et al., 2007). REM 
segments exhibited the following features: low-amplitude, mixed-frequency EEG 
activity, absence of K complexes and sleep spindles and decrease in chin tone with 
rapid eye movements following within 1 epoch as determinants of the exact point of 
REM onset.  
Figures 7 and 8 depict representative polygraphs of EEG frequencies and 
respiration during the transition from non-REM to REM sleep in a cSCI and AB subject, 
respectively.  Able-bodied subjects had a larger drop in ventilation with REM onset than 
SCI subjects (Table 5). 
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Figure7. Ventilation during Transition from Non-REM to REM Sleep in Spinal Cord 
Injury 
Panel A: A 30 second polygraph with EEG and EMG recording in a cervical (C7, 
complete injury) SCI individual (28 year old male, BMI 31.0 kg/m2) during the transition 
from NREM to REM sleep. E: eye, M: mastoid ground, C: central, O: occipital. Panel B: 
A 30 seconds polygraph with ventilation recording, time matched to the EEG data in 
panel A. Note the absence of a large drop in flow and tidal volume coinciding with REM 
onset in this cervical SCI subject compared to an able-bodied subject in Figure 8.  
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Figure 8. Ventilation during Transition from Non-REM to REM Sleep in an Able-
bodied Subject 
Panel A: A 30 second polygraph with EEG and EMG recording in an able-bodied control 
subject (68 year old male, BMI 23.6 kg/m2) during the transition from NREM to REM 
sleep. E: eye, M: mastoid ground, C: central, O: occipital. Panel B: 30 A seconds 
polygraph of ventilation recording, time matched to the EEG data in panel A. Note the 
large drop in flow and tidal volume with REM onset in this able-bodied subject.  
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Table 5. Tidal Volume During Non-REM to REM Transitions 
 Non-REM REM 
cSCI   
1c 763.8±93.2 710.6±155.4 
2c 295.5±56.5 269.2±106.8 
3c 232.5±40.9 290.4±81.6 
tSCI   
1t 279.9±47.2 212.6±128.4 
2t 249.3±93.6 247.3±51.3 
Able-Bodied   
1AB 448.7±42.5 322.9±148.0 
2AB 434.0±22.4 394.3±71.1 
3AB 470.8±26.9 153.4±85.3 
cSCI: cervical SCI; tSCI: thoracic SCI; Tidal Volume (mL). Non-
REM: average of the 10 breaths of non-REM sleep just prior to REM 
onset for each subject ± S.D.  REM: average of the first 10 breaths 
in REM sleep for each subject ± S.D. Each subject is denoted by a 
number followed by c for cervical SCI, t for thoracic SCI or AB for 
able-bodied. 
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Discussion 
Summary of findings 
The purpose of this study was to identify the ventilatory changes at sleep onset 
during the transition from alpha to theta EEG frequencies. The major findings of this 
study were: 1) Sleep onset was associated with hypoventilation in individuals with 
chronic SCI compared to able-bodied subjects.  2) Sleep onset hypoventilation was 
predominantly present in participants with cervical but not thoracic SCI, and 3) There 
was no change in upper airway resistance in either group.  
 
The effect of sleep onset on ventilation and timing in spinal cord injury 
The current study demonstrated that the loss of the wakefulness stimulus to 
breathe was associated with decreased VE and increased PETCO2 in individuals with 
SCI but not in able-bodied participants. Decreased ventilation was not due to increased 
upper airway resistance. Thus, altered upper airway mechanics were not responsible for 
the sleep onset hypoventilation in individuals with SCI.  
Evidence in the literature suggests that sleep onset is associated with transient 
breathing instability and a decrease in ventilation, even in healthy individuals (Douglas 
et al., 1982; Colrain et al., 1987; Trinder et al., 1992; Dunai et al., 1999). Trinder and 
colleagues reported a 19% drop in VT during alpha to theta transitions in healthy adult 
males and a 13% decrease in females (Trinder et al., 1992). Our study did not consider 
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gender differences, but we found no significant (<10%) decrease in VT in theta 
compared with alpha in the AB group; the reasons for the difference in findings is 
currently unclear.  
 Putative Mechanisms of Sleep Onset Hypoventilation in SCI 
The major finding in our study was a greater drop in VT at sleep onset in SCI 
compared to able-bodied individuals. Moreover, VT drop was related to the level of injury 
and was greater in cervical SCI, who have significant ventilatory instability in 
comparison to able-bodied subjects (Sankari et al., 2014a). Consistent with previous 
work (Kay et al., 1996), we found that upper airway resistance does not explain the 
decrease in ventilation at sleep onset. We therefore suggest that other factors that may 
contribute to ventilatory instability during sleep onset such as state-related fluctuations 
in the drive to the primary respiratory muscles and variability in compensatory 
mechanisms. 
We considered several possible mechanisms of sleep-onset hypoventilation in 
SCI subjects. First, chest wall deformities, such as in mid- and high thoracic SCI, might 
contribute to increased mechanical loading and reduced lung volume leading to 
hypoventilation (Castriotta and Murthy, 2009). Second, reduced central ventilatory drive 
may cause hypoventilation in subjects with SCI, especially cervical SCI (Manning et al., 
1992).  There is evidence from animal studies that central ventilatory drive may be 
diminished in cervical SCI (Zimmer and Goshgarian, 2007). This is unlikely in our study 
as there was no difference in ventilation or PETCO2 during wakefulness in SCI vs. able-
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bodied control subjects. Whether SCI is associated with a more pronounced sleep-
related decrease in central ventilatory motor output cannot be determined from our data.   
Third, sleep onset hypoventilation may be influenced by peripheral 
chemoreceptor activity. A previous study suggested an interaction between chemical 
stimuli and state effects on ventilation during sleep-onset (Dunai et al., 1999). 
Specifically, individuals with increased peripheral chemoreceptor activity displayed 
amplified state-related changes in ventilation and subsequent dampening following 
hyperoxic exposure. However, sleep onset hypoventilation was more pronounced in 
cervical SCI subjects even when compared to able-bodied individuals with SDB, a 
group that is known to have augmented peripheral chemoreceptor activity.  
Finally, individuals with spinal cord injury are more susceptible to sleep onset 
hypoventilation than healthy individuals, owing to the denervation of some, or all, 
intercostal muscles (8, 20, 29). Evidence in the literature suggests that rib cage 
contribution to VT increases by 20% during non-REM sleep relative to wakefulness (28). 
Therefore, we interpret accentuated sleep-onset hypoventilation in individuals with 
tetraplegia as secondary to loss of intercostal muscle activity. The attenuation of non-
REM to REM hypoventilation in subjects with cervical spine injury supports this 
interpretation. However, our study precludes drawing firm conclusions regarding the 
relative contribution of the loss of intercostal muscle activity versus increased peripheral 
chemoreceptor activity on sleep-onset hypoventilation. In summary, our study 
demonstrated an augmented sleep-related hypoventilation in patients with SCI, mostly 
in subjects with cervical SCI and without significant changes in upper airway resistance.    
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Physiologic Implications 
Sleep-onset hypoventilation may contribute to sleep-related breathing instability. 
Individuals with SCI can maintain stable sleep and alveolar ventilation despite modest 
hypoventilation. However, significant hypoventilation may occur in individuals with a 
high spinal level of SCI and abnormal respiratory mechanics or those who use CNS 
suppressing medications. Sankari and colleagues have previously shown that 
tetraplegia is a risk factor for central apnea owing to increased plant gain (Sankari et al., 
2014b). Therefore, sleep onset hypoventilation may increase the propensity to develop 
central apnea by increasing plant gain. The ensuing sleep fragmentation may lead to 
ventilatory overshoot and recurrent episodes of apnea/hypopnea alternating with 
hyperpnea (Douglas et al., 1982; Douglas, 1992; Badr, 2005; Eckert et al., 2007; 
Yumino and Bradley, 2008; Nemati et al., 2011). Therefore, sleep-onset hypoventilation 
may promote the development of recurrent central apnea and sleep-related breathing 
instability in subjects with SCI.  
Conclusions 
  We have shown the occurrence of significant sleep-onset hypoventilation in 
patients with chronic SCI compared to able-bodied subjects. The magnitude of sleep 
onset hypoventilation is not associated with increased upper airway resistance and is 
related to the level of SCI. Diminished neuromuscular output owing to intercostal muscle 
paralysis could play a role in the development of sleep apnea post-injury to the cervical 
spine. 
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CHAPTER 2 
The Role of Chemoreflexes in Breathing Instability and Sleep 
Disordered Breathing in Chronic Spinal Cord Injury  
 
Introduction 
The incidence of spinal cord injury (SCI) is estimated to be 12,500 new cases 
each year in the United States alone. Approximately 59% of cases result in tetraplegia 
(NSCISC Facts and Figures at a Glance, 2014). While less than 10% of SCI patients 
will require mechanical ventilatory support beyond 1 year of injury, respiratory 
complications (i.e. pneumonia)  remains the primary cause of death after SCI (NSCISC 
2013 Report). Patients with cervical (cSCI) and high thoracic (tSCI) injuries are at the 
greatest risk for respiratory-related complications due to impairment of neural outflow to 
critical respiratory muscles.  
Sleep disordered breathing (SDB) is a major cause of morbidity and impaired 
quality of life in patients with SCI. Recent reports found that more than half of SCI 
patients developed SDB in their first year post-injury (62% have AHI >10 event/hour). In 
fact, SCI may be an independent risk factor for the development of SDB (Sankari et al, 
2014b).  Berlowitz and colleagues (2005) followed a cohort of cSCI patients from the 
acute  to the chronic phase of injury and reported that at 2 weeks post-injury 60% had 
SDB (apnea hypopnea index >10) , the incidence rose to 83% by week 13, and fell to 
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62% by 52 weeks (Berlowitz et al., 2005). Other studies published over the past 2 
decades by various investigators have placed the prevalence of SDB to be between 27-
77% (Star et al., 1988; Bonekat et al., 1990; Short et al, 1992; Levi et al., 1995; McEvoy 
et al., 1995; Klefbeck et al., 1998; Burns et al., 2000; Stockhammer et al., 2002; Biering-
Sorenson et al., 2009; Sankari et al., 2014a).  
The specific type of SDB experienced after SCI is a matter of debate. The 
majority of studies places SDB in SCI under the classification of obstructive sleep apnea 
(OSA). However, Sankari et. al. (Sankari et al., 2014a) studied a group of 26 
consecutively enrolled chronic SCI subjects (15 cSCI, 11 tSCI) and reported that 
approximately 93% of cervical and 55% of thoracic SCI patients had symptomatic SDB 
as defined by an apnea hypopnea index (AHI) >5 events per hour and excessive 
daytime sleepiness. Another significant finding of this study was that the majority of 
cSCI had central sleep disordered breathing (CSDB) and periodic breathing (PB) (60%) 
in the absence of heart disease and irrespective of narcotic use, compared to tSCI 
subjects who primarily exhibited OSA (18% had CSA and 27% had PB) (Sankari et al, 
2014a). Central SDB occurs in <1% of the general adult population and is typically 
found in patients with systolic heart failure, those ascending to high altitudes, and opiate 
users (White et al., 2005; Panossian et al., 2009), although some studies report that the 
incidence of CSA increases with age (Wellman et al., 2007). Central sleep apnea can 
also occur concomitantly with OSA (Morgenthaler et al., 2007; Salloum et al., 2010; 
Chowdhuri et al, 2012). One reason for the common classification of SDB in SCI as 
OSA may be due to the insensitivity of diagnostic methods to differentiate between 
central and obstructive events (Yumino and Bradley, 2008). Sankari and colleagues 
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used quantitative flow via pneumotachometer and a pressure tipped airway catheter 
which allows for greater accuracy in diagnosing types of events compared to methods 
commonly used by other investigators (Sankari et al., 2014a).  
The mechanisms underlying the increase in CSDB and PB in chronic SCI are not 
understood. In SCI, one proposed mechanism for CSDB and PB is sleep-related 
hypoventilation (Castriotta and Murthy, 2009). Our lab has observed that patients with 
SCI, particularly cSCI, demonstrate significant sleep onset hypoventilation compared 
with subjects with tSCI and able-bodied controls (Bascom, unpublished observations, 
See Chapter 1). Sleep onset hypoventilation leads to frequent arousals from sleep, 
significant fluctuations in end-tidal CO2 and O2 (PETCO2, PETO2, respectively), increased 
plant gain, and a narrowed CO2 reserve, all of which set the stage for breathing 
instability (Dempsey, 2004). Trinder and colleagues (1993) reported a positive 
correlation between able-bodied subjects who had a large magnitude of sleep onset 
hypoventilation (during the transition from wake to stable non-REM sleep) and breathing 
instability and the degree of respiratory instability during stable sleep (Trinder et al., 
1993). Based on the findings in by Trinder and colleages (1993), Dunai and colleagues 
(1996) postulated that both state-related fluctuations in ventilation and chemical 
influences (i.e. chemoreflexes) may work together during sleep to create breathing 
instability and induce perturbations. Delays in feedback to the peripheral 
chemoreceptors, that are inherent in the respiratory feedback loop, may accentuate 
state-related instability (Dunai et al., 1996). To test this hypothesis Dunai and 
colleagues (1996) identified 2 groups of able-bodied subjects with low and high 
peripheral chemoreceptor drive and examined state-related fluctuations in ventilation 
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during sleep onset. They reported that subjects with high peripheral chemoreceptor 
drive exhibited a significantly greater magnitude sleep onset ventilatory instability and 
hypoventilation than subjects with low peripheral chemoreceptor drive. Furthermore, this 
hypoventilation was mitigated with hyperoxia administration. They concluded that 
heightened peripheral chemoreceptor activity can contribute to SDB (Dunai et al, 1996 
and 1999).  
Indeed, altered chemoresponsiveness has been implicated in CSDB and 
breathing instability by several investigators (Khoo et al., 1982; Dempsey 2004; Eckert 
et al., 2007; Yumino and Bradley, 2008) and may be an important mechanism in the 
development of SDB in chronic SCI.  High chemoreflex sensitivity leads to ventilatory 
overshoot in response to relatively small perturbations, destabilizes breathing, and 
predisposes individuals to CSDB and PB (Dempsey, 2004). The peripheral 
chemoreceptors serve to respond rapidly to adjust ventilation in response to changes in 
O2 and CO2 on a breath-by-breath basis and have been proposed as a key component 
of the ventilatory feedback loop for producing breathing instability in the face of 
feedback delays (Khoo et al., 1982; Longobardo et al., 1982; Younes, 1989).  
 There have been no studies reported that specifically focused on peripheral 
chemoreceptor responsiveness in SCI. The majority of studies have reported blunted 
hypercapnic ventilatory response (HCVR) (Kelling et al., 1985; McCool et al, 1988; 
Manning et al., 1992), which is a measure of peripheral and central chemosensitivity, 
while other investigators have found no significant difference in sensitivity to steady-
state hypoxia and hypercapnia compared with able-bodied controls (Pokorski et al., 
1990 and 1995; Ben-Dov et al., 2009). Since peripheral chemoreceptors respond very 
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rapidly, on a breath-by-breath basis, chemical stimuli that are rapidly administered and 
brief would best take advantage of their specific time response characteristics in order 
to avoid involving the slower responding central chemoreflexes (Black et al.,1967; 
Dutton et al.,1967; Gelfand and Lamberton , 1973).  
Brief hyperoxia has long been established as having an inhibitory effect on the 
carotid body, causing a short-lived decrease in ventilation which has been used as a 
measure of the contribution of the carotid bodies to eupneic breathing (Dejours, 1962; 
Daristotle et al., 1991; Cutz et al., 1997; Gautier 2003).  The use of hyperoxia to assess 
peripheral chemoreceptor tonic drive has well established validity, is safe and well 
tolerated by subjects.  
McClean and colleagues (1988) utilized a similar method of targeting carotid 
body response to CO2 by administering a single breath of CO2 gas via inhalation, and 
measuring the ventilatory response to this brief stimuli (McClean et al., 1988, Martinez, 
2008). The response to brief CO2 administration is a transient (within 10 seconds)  
increase in tidal volume (VT). The time course of this response suggests it is a function 
of peripheral chemoreceptor, as opposed to central chemoreceptors that would require 
up to 60 seconds to manifest (Black and Torrance, 1966; Dutton et al., 1967, Gray, 
1968; Gelfand and Lamberto, 1973). The combination of these two interventions (brief 
hyperoxia and hypercapnia) would allow for the assessment of carotid body 
chemoreflex responses to O2 and CO2 stimuli.  
The hypotheses proposed in my studies are: 1) subjects with chronic SCI will 
have a higher peripheral chemoreceptor contribution to eupneic breathing, as evidenced 
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by a greater magnitude of decrease in ventilation in response to transient hyperoxia, 
and 2) subject with SCI will have a heightened ventilatory response to transient 
hypercapnia compared to able-bodied subjects. In order to test these hypotheses, I 
administered rapid, but brief chemical stimuli to determine the ventilatory response to 
O2 and CO2 in both groups of subjects.  
 Materials and Methods 
Protocols were approved by the Human Investigation Committee of the John D. 
Dingell Veterans Affairs Medical Center and Wayne State University (Detroit, MI) and 
written informed consent was obtained.  
We studied adults (≥18 years old) with chronic SCI and able-bodied participants 
if they met the inclusion and exclusion criteria. All subjects were instructed not to have 
alcohol, caffeine products or sedatives on the day of the study.  
Inclusion Criteria- participants with chronic SCI (>6 months post-injury), spanning 
the spectrum from cervical (cSCI, C4-C7) to thoracic levels (tSCI, T1-T6) (complete and 
incomplete injuries). Able-bodied subjects (AB) were recruited with similar 
demographics to the SCI group for age, body mass index (BMI) and gender.  
Exclusion criteria-Participants were excluded from the study for any of the 
following: (1) pregnant or lactating females; (2) currently ventilator dependent or with 
tracheostomy tube in place; (3) history of cardiac disease including heart failure, 
peripheral vascular disease, or stroke; (4) history of head trauma resulting in 
neurological symptoms or loss of consciousness; (5) advanced lung, liver, or chronic 
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kidney disease; (6) extreme obesity, defined for this protocol as BMI >38 kg/m2; or (7) 
other illness that would interfere with completion of the study.  
Subjects first underwent overnight in-lab polysomnography (PSG) to determine 
the presence or absence of sleep disordered breathing (apnea hypopnea index, 
events/hour; AHI) (Comet PSG System, AS40 Model or the Heritage II PSG System; 
Grass Technologies, Warwick, RI). PSG studies were scored according to American 
Academy of Sleep Medicine (AASM) 2012 recommended criteria (Berry et al., 2012). 
On a separate visit, subjects arrived at the lab between 10 am-4 pm for study. 
Studies were performed in the supine position during wakefulness. Instrumentation 
included electrocardiogram (ECG), electroencephalogram (EEG), electrooculograms 
(EOG) and chin electromyograms (EMG) using the International 10-20 system of 
electrode placement (EEG: C3-A2 and C4-A2; EOG: O-A2). Subjects wore a nasal 
mask connected to a pneumotachometer (Hans Rudolph, Model 3700A, Shawnee, KS) 
that measured airflow. Tidal Volume (VT) was determined via integration of the 
pneumotachometer flow signal. End-tidal carbon dioxide (PETCO2), end-tidal oxygen 
(PETO2) levels and inspired O2 levels (FiO2) were measured with CO2 and O2 gas 
analyzers (Vacumed Model 17515 and 17518 respectively, Ventura, CA). Pulse 
oximetry was measured by an ear probe (Biox 3740, Datex-Ohmeda Inc, Madison, WI). 
Respiratory effort was measured by respiratory inductance plethesmography (RIP) belts 
placed on the chest and abdomen (Q-RIP, Braebon Medical Corp., Ogdensburg, NY). 
Ventilation data from the pneumotachometer, pulse oximeter and gas analyzers were 
digitized and analyzed using a PowerLab Data Acquisition System (Model 16SP, 
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ADInstruments Inc., Colorado Springs, CO). Electroencephalograph, EMG, EOG, ECG, 
and respiratory effort were recorded and analyzed via the Comet PSG system (AS40 
amplifier) or Heritage II system (Grass Technologies, Warwick, RI). EEG was used to 
verify that subjects remained in stable wakefulness during interventions. Medical 
adhesive tape was placed over subject’s lips to help prevent mouth breathing. 
Spontaneous ventilation was recorded for a minimum of 15 minutes prior to any 
intervention. Subjects were instructed that CO2 or O2 would intermittently be 
administered through the nasal mask for a short period of time, in random order, and 
that they were to breathe through their nose. If mouth breathing occurred, tape was 
replaced and the subject was again instructed not to breathe through their mouth. The 
order of interventions (hyperoxia vs. single breath CO2) was randomized to eliminate 
order effect. 
Hyperoxia Methods 
   Oxygen was bled into a port on the mask through O2 tubing attached to a gas 
tank containing 100% O2. Flow was quickly increased to 12-15 L/min until inspired O2 
values reached ≥ 50% in the mask. O2 administration was continued for 1 minute 
followed by 5 minutes of room air breathing between trials. Trials were repeated 3 
times. A representative example of a hyperoxia test in a cSCI subject is depicted in 
Figure 9 and an AB subject in Figure 10.  
Analysis consisted of comparing the average of 10 baseline room air breaths 
immediately preceding hyperoxia with the nadir VT breath within the first 30 seconds of 
hyperoxia. Results of 3 trials per subject were averaged. In one instance in a cSCI 
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subject, only 2 reproducible trials were obtained, so in this case the average of 2 trials 
was used. Ventilation (minute ventilation [VE], VT, and frequency) for the nadir breath 
during hyperoxia was expressed as a percentage of the baseline room air ventilation.  
Nadir hyperoxia ventilation was compared between SCI and AB subjects.  In addition,  
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Figure 9: Effect of Transient Hyperoxia on Ventilation in Spinal Cord Injury 
 A representative polygraph of a 1 minute hyperoxia trial in a 38 year old male cervical 
SCI subject (BMI 28.2 kg/m2). Baseline ventilation on room air preceding hyperoxia is 
followed by a striking decrease in tidal volume during hyperoxia administration. VT: tidal 
volume, PETCO2: end-tidal CO2, PETO2: end-tidal O2, SaO2: oxygen saturation; FiO2: 
concentration of inspired O2.   
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Figure 10: Effect of Transient Hyperoxia on Ventilation in an Able-Bodied Subject 
A representative polygraph of a 1 minute hyperoxia trial in a 56 year old male able-
bodied subject (BMI 25.8 kg/m2). Baseline ventilation on room air preceding hyperoxia 
is followed by a smaller decrease in tidal volume during hyperoxia administration 
compared to that in Figure 1. VT: tidal volume, PETCO2: end-tidal CO2, PETO2: end-tidal 
O2, SaO2: oxygen saturation; FiO2: concentration of inspired O2.   
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average time (in seconds) to nadir breath during hyperoxia and average inspired % O2 
(FiO2) were calculated and compared between groups.  
A sub-analysis was performed to compare the response to transient hyperoxia in 
cervical vs. thoracic SCI subjects to determine if spinal injury level influences the 
response. In addition, analyses were performed for all subjects to determine if AHI 
correlates with the ventilatory response to hyperoxia.  
Single Breath CO2 Methods 
Single breath CO2 tests (SBCO2) using the instrumentation and conditions 
described above were performed.  While breathing room air, CO2 was bled into a port 
on the mask via small bore tubing connected to a gas blender (Model PMR4, 
Orangeburg, NY), which was in turn connected to a gas tank containing 40% CO2 
balanced with N2.  Gas flow was adjusted to reach a target of 8-10% inspired CO2 for a 
single breath. Flow was adjusted to administer approximately 8-10% inspired CO2 
during expiration of one breath to load the circuit and continued until peak inspiration of 
the following breath before being abruptly terminated. Figures 11 and 12 demonstrate 
trials of SBCO2 in a cSCI and AB subject, respectively. Trials were preformed 3 times 
with 2-3 minutes between trials.  
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Figure 11: Effect of Transient Hypercapnia on Ventilation in Spinal Cord Injury 
A representative polygraph of a single breath CO2 test in a 28 year old male cervical 
SCI subject (BMI: 31.5 kg/m2). Baseline room air ventilation is compared with the 
response breath (largest VT within 5 breaths of CO2 ) after administration of 1 breath of 
CO2 (“CO2 stimulus breath”). Note the large increase in tidal volume in the response 
breath after CO2 administration in a SCI subject compared to the response breath in 
Figure 12, an able-bodied subject.  VT: tidal volume, PETCO2: end-tidal CO2, PETO2: end-
tidal O2, SaO2: oxygen saturation; FiO2: concentration of inspired O2. ∆PETCO2:PETCO2 
after CO2 administration minus the average PETCO2 for baseline room air breaths prior 
to test. 
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Figure 12: Effect of Transient Hypercapnia on Ventilation in an Able-bodied 
Subject 
A representative polygraph of a single breath CO2 test in a 30 year old male able-
bodied subject (BMI: 22.9 kg/m2). Baseline room air ventilation is compared with the 
response breath after administration of 1 breath of CO2 (“CO2 stimulus breath”). Note 
the relatively small increase in tidal volume in the response breath (largest VT within 5 
breaths of CO2) after CO2 administration of the able-bodied subject in this figure, 
compared to the response in Figure 11, a SCI subject.  VT: tidal volume, PETCO2: end-
tidal CO2, PETO2: end-tidal O2, SaO2: oxygen saturation; FiO2: concentration of inspired 
O2.  ∆PETCO2:PETCO2 after CO2 administration minus the average PETCO2 for baseline 
room air breaths prior to test.  
56 
 
 Analysis consisted of averaging the 5 breaths of baseline room air ventilation (VE 
and PETCO2) immediately prior to CO2 administration for comparison with the “response 
breath”, which was taken as the largest breath based on VT within the first 5 breaths 
after administration. The chemoreflex response to a single breath of CO2 was calculated 
as ∆VE/∆CO2 (L/min/mmHg). In addition, the VT and VE of the response breath was 
expressed as a percentage of the average VT and VE, respectively, for baseline room air 
breaths. Time from CO2 breath to response breath was calculated in seconds, as well 
as average inspired CO2. Results were averaged for 3 trials in each subject and 
outcomes were compared between SCI and AB groups.  
A sub-analysis was performed to compare the response to a single breath of CO2 
in cervical vs. thoracic SCI subjects to determine if spinal injury level influences the 
response. In addition, analysis was for all subjects to determine if AHI correlates with 
SBCO2 response.  
Statistical Analysis 
T-tests were used to compare outcome measures and demographic data 
between the SCI and AB groups, or between cSCI and tSCI, when data was normally 
distributed. If data was not normally distributed, non-parametric tests were employed 
(SigmaPlot 12.1). Pearson Product Moment Correlation was performed to determine the 
relationship between AHI and ventilatory response to chemical stimuli. All data are 
reported as mean ± SD and significance was set at p<0.05. 
Results 
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Hyperoxia in SCI vs. Able-bodied Subjects 
Fifteen subjects with chronic SCI and 15 AB subjects with similar demographics 
(Table 6) were studied to determine the ventilatory response to hyperoxia. Figure 13 
illustrates that SCI subjects had a significant decrease in VT (63.4±21.7 % baseline) and 
VE (63.1±23.0 % baseline) with hyperoxia compared to AB subjects (VT: 87.1±14.3 % 
baseline, VE: 91.38±15.1 % baseline), while frequency was not different in either group. 
The time from initiation of hyperoxia to the nadir breath was similar in both groups (SCI: 
20.2±3.6 sec. AB: 18.3±5.4 sec, p=0.26) as was the average FiO2 administered for all 
hyperoxia trials (SCI: 73.0±11.5% vs. AB: 71.2±8.7%, p=0.63). There was no significant 
correlation between AHI and VE% baseline (r=-0.28) in SCI and AB (n=30). Subjects 
with SCI had a greater magnitude of inhibition of peripheral chemoreceptors in response 
to brief hyperoxia than able-bodied subjects.  
  
58 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6. Subject Characteristics 
 Hyperoxia Single Breath CO2 
   
 SCI Able-Bodied SCI Able-Bodied 
N 15 15 12 12 
Age (years) 40.7±13.4 41.3±18.3 39.8±13.2 41.3±16.6 
BMI (kg/m2) 25.8±5.4 27.4±4.1 27.0±5.1 26.9±4.1 
Gender (M/F) 11/4 10/5 9/3 9/3 
AHI (events/hour) 20.0±17.4 11.7±18.2 21.2±19.3 12.7±20.3 
Injury level 
(cervical/thoracic) 
8/7 __ 6/6 __ 
All data Mean ±SD.  BMI: Body Mass Index, AHI: Apnea Hypopnea Index. No significant 
difference in age, BMI, gender or AHI (p >0.05).  
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Figure 13: Comparison of Response to Hyperoxia in Spinal Cord Injury and Able-
bodied Subjects 
Minute ventilation (VE), tidal volume (VT) and frequency (Freq) during hyperoxia 
administration in spinal cord injury (SCI) and able-bodied (AB) subjects are expressed 
as a percentage of baseline room air ventilation prior to intervention. SCI subjects had a 
significant decrease in VE and VT with hyperoxia (*p<0.001, ǂ p=0.001) compared to AB 
subjects. There was no significant change in frequency in either group (p=0.43). 
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Hyperoxia in Cervical vs. Thoracic SCI Subjects 
 
To determine the effect of spinal injury level on ventilatory response to transient 
hyperoxia, cSCI (n=8) vs. tSCI (n=7) subjects were compared (Table 7). There was no 
significant difference in the nadir breath VT or VE or frequency expressed as a % of 
baseline ventilation during hyperoxia trials. Results are detailed in Table 8. There was 
no difference in time to response to hyperoxia (cSCI: 21.4±3.8 sec, tSCI: 18.7±30. sec; 
p=0.8), or average trial FiO2 (cSCI: 72.9±9.2%, tSCI: 73.2±14.4%; p=0.96). There was 
no significant correlation between AHI and SBCO2 response in SCI subjects (n=15) (r=-
0.40). Thus, injury level had no effect on ventilatory response to brief hyperoxia.  
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Table 7. Cervical and Thoracic SCI Subject Characteristics 
 
Hyperoxia Single Breath CO2 
   
 Cervical Thoracic Cervical Thoracic 
N 8 7 6 6 
Age (years) 42.5±13.0 38.7±14.7 40.5±11.0 39.0±16.1 
BMI (kg/m2) 24.4±5.7 27.4±4.9 26.2±5.4 27.8±5.2 
Gender (M/F) 7/1 4/3 5/1 4/2 
AHI (events/hour) 29.0±16.5 9.6±12.4* 33.2±17.0 9.2±13.6ǂ 
All data Mean ±SD.  BMI: Body Mass Index, AHI: Apnea Hypopnea Index. No 
significant difference in age, or gender. (p >0.05). AHI significantly higher in cervical 
vs. thoracic SCI subjects (* p=0.02, ǂ p=0.03). 
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Table 8. Cervical vs. Thoracic SCI Chemoresponse Ventilation  
 Hyperoxia  Single Breath CO2  
     
 Cervical Thoracic p value Cervical Thoracic p value 
N 8 7  6 6  
VE 
(% BASELINE) 
54.5±21.3 72.9±22.1 0.13 172.9±40.3 153.3±23.2 0.33 
VT 
(% BASELINE) 
55.8±20.1 72.1±21.5 0.15 208.9±52.9 157.6±30.4 0.07 
FREQUENCY 
(% BASELINE) 
99.9±33.6 99.1±13.0 1.0 __ __  
SBCO2 
(L/MMHG) 
__ __  0.82±0.48 0.74±0.39 0.75 
 All data Mean ±SD.  SBCO2: Ventilatory Response to a single breath of CO2 
(∆VE/∆CO2). No significant difference in any chemoreflex responses between 
cervical and thoracic SCI subjects.  
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Single Breath CO2 in SCI vs. Able-bodied Subjects  
Twelve subjects with chronic SCI and 12 AB subjects with similar demographics 
(Table 6) were studied to determine the response to a single breath of hypercapnia. The 
ventilatory response to SBCO2 (∆VE/∆CO2) was significantly higher in the SCI group 
compared with the AB group, as detailed in Figure 14. Tidal volume for the response 
breath after CO2 administration, expressed as a percentage of baseline room air 
ventilation, was also significantly increased in SCI compared to AB subjects 
(183.2±49.1 % vs. 125.7±13.6%, respectively, p<0.05). Similarly, VE increased to a 
greater degree in SCI subjects compared to AB subjects (163.1±33.0 % vs. 
118.5±4.8%, respectively, p<0.05). The average inspired CO2 for SBCO2 trials was not 
different between SCI and AB groups (8.7±1.6% vs. 8.0±1.3%, respectively, p=0.24) nor 
was the time from CO2 administration to the response breath (SCI: 10.6±4.2 sec; AB: 
11.9±4.1 sec, p=0.44). No significant correlation was found between AHI and SBCO2 
response in SCI and AB subjects (n=24) (r=0.27). 
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Figure 14: Comparison of Response to Brief Hypercapnia in Spinal Cord Injury vs. 
Able-bodied Subjects 
The ventilatory response to a single breath of CO2 (SBCO2 L/min/mmHg) was 
significantly higher in SCI subjects compared to able-bodied subjects (AB) (*p<0.001).  
 
 
65 
 
Single Breath CO2 in Cervical vs. Thoracic SCI Subjects 
 
In order to determine the contribution of spinal injury level to the response to a 
single breath of CO2, cervical (n=6) vs. thoracic (n=6) SCI subject’s responses were 
compared. Table 7 describes the characteristics of the cervical and thoracic SCI groups. 
There was no difference in SBCO2 (∆VE/∆CO2) response between cSCI and tSCI 
subjects (Table 8). Similarly, no difference was found in VE or VT expressed as a 
percentage of baseline ventilation between injury levels (Table 8). In addition, no 
difference was found in time from inspiration of CO2 to response between cSCI 
(12.0±5.6 sec) and tSCI subjects (9.2±1.8 sec; p=0.28).  The inspired CO2 level for trials 
were not different between groups (cSCI: 8.9±1.4%, tSCI: 9.2±1.8; p=0.59). There was 
no significant correlation between AHI and SBCO2 response in SCI subjects (n=12) 
(r=0.27).  
Discussion 
The purpose of this study was to determine the peripheral chemoreflex 
responses to brief hyperoxia and hypercapnia in chronic SCI and AB subjects. The 
major findings of the study were: 1) Subjects with SCI have a greater magnitude of 
reduction in ventilation in response to brief hyperoxia than AB. 2) SCI participants had a 
greater ventilatory response to a single breath of CO2 than AB. 3) There was no 
difference in peripheral chemoreceptor response to brief hyperoxia or hypercapnia in 
cervical vs. thoracic SCI. 4) Peripheral chemoresponsiveness was not significantly 
correlated with AHI in SCI and AB subjects.  
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Peripheral chemoreceptor response to transient hyperoxia 
The carotid body supplies a tonic excitatory input to central respiratory centers 
and contributes to eupneic ventilatory drive. Peripheral chemoreceptors are of great 
importance in maintaining ventilatory homeostasis during non-REM sleep when 
wakefulness inputs from higher brain centers are absent (Forester, 2000). The 
receptors have been postulated to be involved in the development of SDB (Khoo et al., 
1982; Dempsey, 2004; Eckert et al., 2007; Yumino and Bradley, 2008). In this study I 
utilized brief hyperoxia to suppress the tonic drive of the carotid body to assess the 
putative contribution the carotid body to eupneic ventilation in SCI and AB subjects.   
Hyperoxia has been reported to reduce ventilation transiently in adults by ~10% 
thus unmasking the oxygen-led drive to breathe, mediated by the peripheral 
chemoreceptors (Dejours, 1962; Gautier, 2006).  In the current study, AB subjects had a 
decline in VE of ~9% with hyperoxia, in agreement of historical data, compared to SCI 
subjects with ~37% decline.  From this I conclude that SCI subjects have an increased 
peripheral chemoreceptor gain and a heightened reliance on the carotid body for 
maintenance of eupneic ventilation.   
Peripheral chemoreceptor response to brief hypercapnia 
Studies of chemosensitivity to CO2 in an animal model, utilizing an isolated 
perfusion of the carotid body, found that central chemoreceptors respond in a slower 
fashion to CO2 stimulation compared to the carotid body (30.9 sec vs. 19.6 sec, 
respectively). Therefore, the carotid body contributes significantly to the ventilatory 
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response to brief oscillations in CO2 (Smith and Dempsey, 2006) such as were 
administered in the current study. The methods used to determine the ventilatory effect 
of transient hypercapnia in this study utilize the response characteristic unique to 
peripheral chemoreceptors. 
McClean et al. (1988) using similar methods to determine the response to transient CO2 
in able-bodied adults (26 males and 26 females) found the average response to be 
~0.34 L/min/mmHg (no significant gender or age effect was found) whereas able-bodied 
subjects in the current study had an average response of ~0.26 L/min/mmHg (vs. SCI 
with ~0.78 L/min/mmHg) (McClean et al., 1988). One reason for the slightly higher 
response in the McClean et al. study may be their use of 13% inspired CO2 while the 
current study utilized 8-9% CO2. However, the time response in both studies were 
consistent, with an average of 10-12 seconds from CO2 administration to response.  
During PB and CSDB, as is frequently found in cSCI, individuals are exposed to 
frequent cycles of hypopnea and hyperpnea, and corresponding oscillations in O2 and 
CO2. If the carotid body has enhanced sensitivity to these rapid changes, as was found 
in SCI subjects in the current study, ventilatory overshoot and undershoot are likely to 
occur and perpetuate or worsen breathing instability (Smith and Dempsey, 2006).  
Putative Mechanisms 
This study demonstrated increased peripheral chemoreceptor activity and 
responsiveness in patients with SCI during wakefulness. I considered several potential 
mechanisms including age, gender, SDB and chronic intermittent hypoxia. There was 
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no difference in the age or gender distribution of the two groups. Similarly, both groups 
included patients with SDB. Chronic SCI patients are likely to suffer from repetitive 
episodes hypoxia over several years. Chronic intermittent hypoxia (CIH, intermittent 
hypoxia: IH), especially during sleep, results in the development of sensory long-term 
facilitation (LTF), which manifests as increased peripheral chemoreceptor activity AND 
enhanced propensity to develop LTF following acute episodic hypoxia (Peng, 2003a 
and 2003b; Prabhakar, 2011). Interestingly, patients with SCI demonstrate both 
features. Tester and colleagues (2014) demonstrated that chronic SCI subjects (cervical 
and thoracic), after being exposed to eight 2-minute episodes of IH, exhibited LTF for 30 
minutes. Sensory LTF, secondary to CIH is a time-dependent phenomenon that is 
completely reversible over time following re-oxygenation. Sensory LTF does not depend 
on the severity of hypoxia used for IH conditioning and is not species specific. 
Enhanced LTF and increased peripheral chemoreceptor activity is consistent with CIH-
induced sensory LTF (Figure 15) (Peng, 2003a; Prabhakar, 2011).  
  
69 
 
 
 
Figure 15. Chronic Intermittent Hypoxia and Sensory Long-Term Facilitation 
A schematic representation of the process by which chronic intermittent hypoxia 
leads to long-term facilitation and enhancement of chemoreflex response to O2 and CO2 
fluctuations. This is a proposed mechanism for breathing instability and sleep 
disordered breathing in chronic SCI.  
 
 
Future studies to test peripheral chemoreflex responsiveness in chronic SCI 
subjects before and after treatment with CPAP, or an alternative treatment, to eliminate 
the CIH associated with hypoventilation and SDB, would allow investigators to test the 
hypothesis that CIH is a key mechanism in the development of augmented peripheral 
chemosensitivity in SCI.  
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FINAL CONCLUSIONS 
Summary of Results 
The results of my first aim (chapter 1) indicate that subjects with chronic cervical 
SCI subjects experience a greater magnitude of sleep onset hypoventilation (significant 
reduction in VE, VT, and increase in PETCO2)  compared to able-bodied subjects, which 
cannot be explained by upper airway mechanics (no significant change in upper airway 
resistance was found in either group). I have postulated that putative mechanisms 
include: 1) loss of intercostal innervation resulting in reduced respiratory pump 
musculature, 2) increased peripheral chemoreceptor gain which has been shown to 
cause increased breathing instability with sleep onset (Dunai et al., 1999) or, 3) 
decreased central respiratory drive (Manning et al., 1992).  
The major findings of my second aim (chapter 2) are that subjects with chronic 
cervical and high thoracic SCI have a greater reduction in ventilation in response to brief 
hyperoxia compared to able-bodied subjects, and a heightened response to a single 
breath of CO2, both indicators of increased peripheral chemoresponsiveness. In 
addition, peripheral chemoresponsiveness was not significantly correlated with AHI in 
SCI and AB subjects. From these results I conclude that SCI subjects have an 
increased peripheral chemoreceptor gain and a heightened reliance on the carotid body 
for maintenance of eupneic ventilation.   
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Clinical Significance 
Both hypoventilation (Castriotta and Murthy, 2009) and high peripheral chemoreceptor 
gain (Dempsey, 2004) have been implicated in the development of SDB in the general 
population.  SDB is associated with excessive daytime sleepiness, impaired cognition 
and increased morbidity and mortality due to effects on the cardiovascular system, 
which include: hypertension, coronary artery disease (CAD), pulmonary hypertension, 
heart failure, cardiac arrythmias and increased risk of stroke (Gopalakrishnan and Tak, 
2001; Mohsen and Urbano, 2011; Chou et al., 2012; Johansson et al., 2012).  The high 
prevalence of SDB in the SCI population makes the study of this disorder of critical 
importance. Investigating the underlying mechanisms, and contributing factors, as was 
done in the studies I have reported, will help in the development of targeted treatment 
that can mitigate the negative health effects of this disorder as well as improve quality of 
life for SCI patients.  
 
Future Directions 
 Future studies to elucidate the mechanism of hypoventilation with sleep onset in 
SCI may include: 1) assessment of intercostal and diaphragm EMG during sleep onset 
to determine the contribution of respiratory muscles to over-all ventilation in SCI vs. 
able-bodied subject, 2) assessment of sleep onset ventilation with and without 
hyperoxia (as in Dunai et al., 1999), 3) assessment of peripheral chemoreceptor reflex 
response before and after treatment to alleviate sleep related hypoxia, 4) administration 
of P0.1 measurements during wake and sleep in SCI and able-bodied subjects to 
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assess central ventilatory drive, or 5) a trial of central respiratory stimulants (such as 
acetazolamide or theophylline) to determine if SDB improves when central drive in 
increased in SCI. While much is still left to learn about the etiology of SDB after SCI, the 
current studies have indicated 2 important contributing factors (sleep onset 
hypoventilation and high peripheral chemoreceptor gain) that point the way to future 
investigations.  
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A high prevalence of sleep-disordered breathing (SDB) after spinal cord injury (SCI) has 
been reported in the literature; however, the underlying mechanisms are not well 
understood. My studies had 2 aims: 1) to determine the effect of the withdrawal of the 
wakefulness drive to breathe on the degree of hypoventilation in SCI patients and able-
bodied controls and 2) to determine the response of the peripheral chemoreceptors to 
brief hyperoxia (60 seconds of >60% FiO2) and hypercapnia (a single breath of elevated 
CO2). I studied subjects with chronic cervical and high thoracic SCI and matched able-
bodied subjects. For the first aim subjects underwent polysomnography, which included 
quantitative measurement of ventilation, timing, and upper airway resistance (RUA) on a 
breath-by-breath basis during transitions from wake to stage N1 sleep. Compared to 
able-bodied controls, SCI subjects had a significantly greater reduction in tidal volume 
during the transition from wake to N1sleep (from 0.51±0.21 L   to 0.32±0.10 L vs. 
0.47±0.13 L to 0.43±0.12 L; respectively, p<0.05). Moreover, end-tidal CO2 and O2 were 
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significantly altered from wake to sleep in SCI (38.9±2.7 vs. 40.6±3.4 mmHg; 94.1±7.1 
vs. 91.2±8.3 mmHg; respectively, p˂0.05), but not in able-bodied controls (39.5±3.2 vs. 
39.9±3.2 mmHg; 99.4±5.4 vs. 98.9±6.1 mmHg; respectively, p=ns). RUA was not 
significantly altered in either group.  In aim 2 SCI subjects had a greater reduction in 
ventilation with hyperoxia administration (63.9±23.0 % of baseline VE) compared to 
able-bodied subjects (91.4±15.1 % of baseline VE, p<0.05) and a higher ventilatory 
response to a single breath of CO2 (SCI: 0.78±0.4 L/min/mmHg vs. able-bodied: 
0.26±0.1 L/min/mmHg, p<0.05). In conclusion, individuals with SCI experience 
hypoventilation at sleep onset, which cannot be explained by upper airway mechanics 
and a high peripheral chemoreflex response to O2 and CO2. Sleep onset hypoventilation 
and high peripheral chemoresponsiveness may contribute to the development SDB in 
the SCI population. 
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